The pharmacokinetics of brensocatib in participants with renal impairment following a single oral administration
British Journal of Clinical Pharmacology · 2025
DOI: 10.1111/bcp.16344 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift British Journal of Clinical Pharmacology, 2025. Verfasst von Sam Au Yeung und 3 weiteren Autor:innen. Beteiligte Einrichtung: Insmed Incorporated, Bridgewater, NJ, United States. Hauptthemen laut MEDLINE: Renal Insufficiency, Dipeptidyl-Peptidase IV Inhibitors. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Insmed.
Abstract (Originalsprache)
Aim
Brensocatib is an oral, selective, competitive and reversible dipeptidyl peptidase 1 inhibitor in development for the treatment of bronchiectasis. This study evaluated the pharmacokinetics (PKs), safety and tolerability of brensocatib in participants with varying degrees of renal impairment and normal renal function.
Methods
In this phase 1, multicentre, open‐label study, 28 participants with mild, moderate or severe renal impairment (estimated glomerular filtration rate [eGFR] 60 to
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Insmed Incorporated, Bridgewater, NJ, United States.
- Orlando Clinical Research Center, Orlando, FL, United States.
Förderung
- Insmed
Zitieren
APA
Yeung, S. A., Stein, D. S., Marbury, T. C., & Usansky, H. (2025). The pharmacokinetics of brensocatib in participants with renal impairment following a single oral administration. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.16344
Vancouver
Yeung SA, Stein DS, Marbury TC, Usansky H. The pharmacokinetics of brensocatib in participants with renal impairment following a single oral administration. British Journal of Clinical Pharmacology. 2025. doi:10.1111/bcp.16344
BibTeX
@article{Yeung2025,
author = {Yeung, Sam Au and Stein, Daniel S and Marbury, Thomas C and Usansky, Helen},
title = {The pharmacokinetics of brensocatib in participants with renal impairment following a single oral administration},
journal = {British Journal of Clinical Pharmacology},
year = {2025},
doi = {10.1111/bcp.16344}
}
EUVIMED